Approval · Notice of Compliance 5518 · 1994
SUFENTA: Notice of Compliance 5518
Issued June 23, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5518
- Date
- June 23, 1994
- Company
- Janssen PharmaceuticaBeerse, Saone Et Loire, Belgium
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate source of finished product
- Therapeutic class
- Narcotic analgesic / adjunct to anesthesia
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUFENTA | Not yet assigned | — |
Medicinal ingredients
- SUFENTANIL CITRATE 50 MCG per ML